NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Antiviral


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on diabetes published by R. Holmberg and colleagues
2009 NOV 23 ... Sweden report. "Combination therapy including LV-antiserum and an antiviral drug, Pleconaril, significantly reduced the levels of blood glucose and insulin and the ...
Subject: Diabetes
Price: $3.00
*
Inhibitex Reports Third Quarter 2009 Financial Results
2009 NOV 28 ... continue to make progress on all fronts, including the advancement of our differentiated antiviral development programs and most recently, the completion of a financing that we believe ...
Subject: Inhibitex, Inc.
Price: $3.00
*
Kineta, University of Washington Partner on NIH-Funded Project to Develop Vaccine Immune Boosters
2009 NOV 23 ... is a discovery-stage biotechnology company focused on the development of new types of antiviral and autoimmune drugs. The Kineta team has a track record of developing novel drug ...
Subject: Kineta, Inc.
Price: $3.00
*
MicroDose Therapeutx Acquires ViroPharma Portfolio of Investigational Compounds for Treatment of Respiratory Syncytial Virus RSV
2009 NOV 23 ... fusion inhibitor, now called MDT-637. This highly potent compound has demonstrated antiviral activity in preclinical studies in both prophylaxis and treatment, and was generally ...
Subject: MicroDose Therapeutx Inc.
Price: $3.00
*
New chemistry research from M. Sala et al outlined
2009 NOV 27 ... concluded: "The prepared family of the target nucleosides was tested for cytostatic and antiviral activity."Sala and colleagues published their study in Tetrahedron ...
Subject: Chemistry
Price: $3.00
*
New findings from T.A. Kirschberg and co-authors in the area of RNA research published
2009 NOV 23 ... site. Inhibition of enzymatic activity was measured in a biochemical assay, but no antiviral effect was observed," wrote T.A. Kirschberg and colleagues. The ...
Subject: RNA Research
Price: $3.00
*
New hepatitis C virus data have been reported by researchers at University of Milan
2009 NOV 23 ... The researchers concluded: "Following the demonstration of a more potent antiviral effect in terms of sustained virological response rates in Phase III randomized trials, ...
Subject: Hepatitis C Virus
Price: $3.00
*
New retinoblastoma findings from Harvard University, Medical Department described
2009 NOV 23 ... DC 20418, USA. Keywords: City:Boston, State:MA, Country:United States, Antiviral, Cytomegalovirus, DNA, DNA Replication, DNA Research, Enzymes, HPV, Human ...
Subject: Retinoblastoma
Price: $3.00
*
New virology study results from C. Dellanno et al described
2009 NOV 23 ... for testing and biosafety requirements necessary to safely handle it, In this study, the antiviral activity of standard household products was assayed against murine hepatitis virus ...
Subject: Virology
Price: $3.00
*
NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009
2009 NOV 23 ... Affairs. "These data support the unique dual activities of DAS181. Because of its antiviral and anti-asthmatic properties, DAS181 may provide an alternative influenza treatment ...
Subject: Asthma
Price: $3.00
*
Research from A. Takagi and co-authors reveals new findings on antivirals
2009 NOV 23 ... derived from lymphocytic choriomeningitis virus (LCMV) and evaluated its potency as an antiviral vaccine. The intramuscular immunization of mice with the peptide-liposome conjugates ...
Subject: Antivirals
Price: $3.00
*
Research from W.R. Berrington and co-researchers in the area of herpes simplex described
2009 NOV 23 ... had evidence of HSV-1 and HSV-2 coinfection. All patients with viremia were treated with antiviral medications. The most common clinical findings were hepatitis (62%), fever (54%), ...
Subject: Herpes Simplex
Price: $3.00
*
Research on hepatitis C virus detailed by scientists at Rockefeller University, Center for the Study of Hepatitis C
2009 NOV 23 ... "A small-animal model for HCV infection would significantly expedite antiviral compound development and preclinical testing, as well as open new avenues to decipher ...
Subject: Hepatitis C Virus
Price: $3.00
*
Research on multiple sclerosis published by scientists at Technical University of Munich
2009 NOV 23 ... treatment of multiple sclerosis (MS). it is believed that immunomodulatory rather than antiviral activity of interferon beta is responsible for disease amelioration. The impact of ...
Subject: Multiple Sclerosis
Price: $3.00
*
Researchers from Tokai University, Department of Surgery provide details of new studies and findings in the area of breast cancer therapy
2009 NOV 23 ... Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Antimetabolite, Antineoplastic, Antiviral, Breast Cancer, Breast Carcinoma, Clinical Oncology, Clinical Trial Research, ...
Subject: Breast Cancer Therapy
Price: $3.00
*
Scientists at University of Hong Kong, Department of Medicine publish research in hepatitis B virus risk factors
2009 NOV 23 ... nonstructural proteins, have been shown to have oncogenic properties. For HBV infection, antiviral therapy and vaccination have been shown to decrease the risk of HCC," wrote J. Fung and ...
Subject: Hepatitis B Virus Risk Factors
Price: $3.00
*
Studies conducted at National Cancer Center Hospital on acinar cell cancer therapy recently published
2009 NOV 23 ... Therapy, Acinar Cell Cancer, Acinar Cell Carcinoma, Antimetabolite, Antineoplastic, Antiviral, Clinical Oncology, Gastroenterology, Gemcitabine, Immunosuppressant, Oncology, ...
Subject: Acinar Cell Cancer Therapy
Price: $3.00
*
Studies in the area of hepatitis C virus reported from P. Hauser and co-researchers
2009 NOV 23 ... use disorders, patients with these comorbidities have historically been excluded from antiviral therapy for HCV. The authors compared antiviral ...
Subject: Hepatitis C Virus
Price: $3.00
*
Study data from University of Paris update understanding of cancer
2009 NOV 23 ... Country:France, Anticancer Therapy, Antimetabolite, Antineoplastic, Antiviral, Apoptosis, Clinical Trial Research, Clinical Trials, Enzymes, Gemcitabine, ...
Subject: Cancer
Price: $3.00
*
Study results from University of Zurich in the area of HIV/AIDS therapy published
2009 NOV 23 ... (RAMs) were investigated by analysing 6072 genotypic tests." "The antiviral activity of ETV was predicted using different interpretation systems: International AIDS ...
Subject: HIV/AIDS Therapy
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login